Abstract: INTRODUCTION: Goals of care discussions (GCDs) are recommended for patients with cirrhosis but rarely conducted. Since 2017, the Veterans Health Administration has …
Abstract: Despite negative outcomes, hepatic encephalopathy (HE) is not included in the Model for End-Stage Liver Disease (MELD) scores, including MELD 3.0. In a National Veterans …
Abstract: INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD), an increasing public health concern, remains challenging to diagnose and risk-stratify. We …
Abstract: Introduction: Although rates of esophageal adenocarcinoma (EAC) in the United States continue to rise, many patients at risk of disease are not screened. EsoCheck (EC), a …
Abstract: Introduction: Hepatic steatosis is highly prevalent in people living with HIV. It remains unclear whether HIV in patients with metabolic dysfunction-associated steatotic …
Abstract: INTRODUCTION: There is paucity of data on the effectiveness and safety of tofacitinib among elderly patients with ulcerative colitis (UC). METHODS: Through a …
Abstract: BACKGROUND: Weight loss is the mainstay of management for patients with metabolic dysfunction-associated steatotic liver disease. We studied the impact of referral to …
Abstract: INTRODUCTION: Achalasia is a postulated risk factor for esophageal cancer (EC); however, EC-associated risk in achalasia is understudied. We aimed to evaluate EC risk …
Abstract: Introduction: Homelessness adversely affects patient outcomes in broad cohort studies; however, its impact on key liver-related outcomes in patients with cirrhosis is …
Abstract: Previous studies suggest that unmeasured organizational factors drive variability in anesthesia-assisted sedation (AA) use. A mixed-methods study of 11 Veterans Health …